Pune, Maharashtra -- (SBWire) -- 02/19/2019 --North America To Lead The Global Peptide Based Cancer Therapeutics Market
In terms of revenues, North America is expected to dominate the global peptide based cancer therapeutics market in 2017 and beyond. The region's potency in healthcare and a strong presence of various peptide based cancer therapeutic drug manufacturers is supporting the growth of the market in North America. During the forecast period, the market in the region is expected to surge at a robust CAGR.
On the basis of drugs, the bortezomib segment is expected to remain highly attractive throughout the assessment period. The segment currently accounts for around 40% revenue share of the global market. Between 2017 and 2022, the segment is expected to reflect a double-digit CAGR to reach a valuation is excess of US$ 4,725 Mn. It expected to grow at US$ 358.4 Mn annually over the course of the forecast period.
Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=179
Competition Tracking
Fact.MR's report has also profiled key companies that are operating in the global peptide based cancer Therapeutic market, which include AstraZeneca PLC, Allergan plc, Pfizer Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, Abbott, AbbVie Inc., and Valeant Pharmaceuticals International, Inc.
Peptide based cancer therapeutics are yet to become widespread, but the initial low numbers certainly do not suggest any pessimism in the global market. With new developments in delivery, stability, modifications, and preclinical success, future growth potentials of such cancer therapeutics continue to intensify. A slew of new peptides with positive preclinical results are entering into clinical trials that are focused on cancer treatment. Moreover, the application base of peptides is steadily expanding to other therapeutic areas as well. In the near future, the global peptide based cancer therapeutics market is likely to be influenced by the rising prevalence of cancer across the globe. WHO reveals that cancer is one of the leading causes of death worldwide, which accounted for more than 8 million deaths in 2015. Factor as such are expected to play an important role in boosting the popularity of peptide based cancer therapeutics further. In addition, various complications involved in conventional cancer therapeutics as well as the risk of sever side-effects are prompting medical professionals to utilise peptides in tumor and cancer treatment. Fact.MR's latest report projects that the global peptide based cancer therapeutics market will surpass a valuation of US$ 11,160 Mn by 2022-end, expanding at an impressive CAGR of 9.2% during the forecast period (2017-2022).
Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=179
Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer. At present, there are a number of peptide based cancer therapeutics available in the market. Incessant medical research on peptides has led to development of several peptide based cancer therapeutics that are showing greater results as compared to conventional cancer therapeutics.
Detailed TOC of Global Peptide Based Cancer Therapeutics Market by Manufacturers, Regions, Type and Application, Forecast to 2022
1. Global Peptide Based Cancer Therapeutics Market - Executive Summary
2. Global Peptide Based Cancer Therapeutics Market Overview
2.1. Introduction
2.1.1. Global Peptide Based Cancer Therapeutics Market Taxonomy
2.1.2. Global Peptide Based Cancer Therapeutics Market Definition
2.2. Global Peptide Based Cancer Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Peptide Based Cancer Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Cancer Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region
Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=179
3. Global Peptide Based Cancer Therapeutics Market Analysis and Forecast By Drug
3.1. Global Peptide Based Cancer Therapeutics Market Size and Forecast By Drug, 2012-2022
3.1.1. Goserelin Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Bortezomib Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
3.1.3. leuprorelin Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
3.1.3.1. Revenue (US$ Mn) Comparison, By Region
3.1.3.2. Market Share Comparison, By Region
3.1.3.3. Y-o-Y growth Comparison, By Region
3.1.4. Others Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
3.1.4.1. Revenue (US$ Mn) Comparison, By Region
3.1.4.2. Market Share Comparison, By Region
3.1.4.3. Y-o-Y growth Comparison, By Region
Access This Report @ https://www.factmr.com/checkout/179/S
4. Global Peptide Based Cancer Therapeutics Market Analysis and Forecast By Distribution Channel
4.1. Global Peptide Based Cancer Therapeutics Market Size and Forecast By Distribution Channel, 2012-2022
4.1.1. Hospital Pharmacies Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Retail Pharmacies Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Online Pharmacies Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
5. Global Peptide Based Cancer Therapeutics Market Analysis and Forecast By Region
5.1. Global Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
5.1.1. North America Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
5.1.1.1. Revenue (US$ Mn) Comparison, By Drug
5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.2. Latin America Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
5.1.2.1. Revenue (US$ Mn) Comparison, By Drug
5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.3. Europe Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
5.1.3.1. Revenue (US$ Mn) Comparison, By Drug
5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.4. Japan Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
5.1.4.1. Revenue (US$ Mn) Comparison, By Drug
5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.5. APEJ Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
5.1.5.1. Revenue (US$ Mn) Comparison, By Drug
5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.6. MEA Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
5.1.6.1. Revenue (US$ Mn) Comparison, By Drug
5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel
6. North America Peptide Based Cancer Therapeutics Market Analysis and Forecast, By Country, 2012-2022
6.1. US Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
6.1.1. Revenue (US$ Mn) Comparison, By Drug
6.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel
6.2. Canada Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
6.2.1. Revenue (US$ Mn) Comparison, By Drug
6.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel
7. Latin America Peptide Based Cancer Therapeutics Market Analysis and Forecast, By Country, 2012-2022
7.1. Brazil Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
7.1.1. Revenue (US$ Mn) Comparison, By Drug
7.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel
7.2. Mexico Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
7.2.1. Revenue (US$ Mn) Comparison, By Drug
7.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel
7.3. Argentina Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
7.3.1. Revenue (US$ Mn) Comparison, By Drug
7.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel
And Continue....
List of Figures, Tables and Charts Available in Global Peptide Based Cancer Therapeutics Market 2017 by Manufacturers, Regions, Type and Application, Forecast to 2022
TABLE 1 Global Peptide Based Cancer Therapeutics Market Value (US$ Mn), 2012-2016
TABLE 2 Global Peptide Based Cancer Therapeutics Market Value (US$ Mn), 2017-2022
TABLE 3 Global Peptide Based Cancer Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Goserelin Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Goserelin Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Goserelin Segment Market Share, By Region 2012-2016
TABLE 7 Global Goserelin Segment Market Share, By Region 2017-2022
TABLE 8 Global Goserelin Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Bortezomib Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Bortezomib Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Bortezomib Segment Market Share, By Region 2012-2016
TABLE 12 Global Bortezomib Segment Market Share, By Region 2017-2022
TABLE 13 Global Bortezomib Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global leuprorelin Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global leuprorelin Segment Value (US$ Mn), By Region 2017-2022
And Continue...
FIG. 1 Global Peptide Based Cancer Therapeutics Market Value (US$ Mn), 2012-2016
FIG. 2 Global Peptide Based Cancer Therapeutics Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Peptide Based Cancer Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global Goserelin Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global Goserelin Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global Goserelin Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global Bortezomib Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global Bortezomib Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global Bortezomib Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global leuprorelin Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global leuprorelin Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global leuprorelin Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Others Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Others Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2022
And Continue...
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://theswisstimes.com
Peptide Based Cancer Therapeutics Volume Forecast and Value Chain Analysis 2018-2020